How we publish—and correct—our work.
Updated October 27, 2026
Our scope
We explain published research and regulatory information. We distinguish human trials from animal and laboratory studies, and distinguish approval of a drug from compounding policy, advisory votes, and seller claims.
Sources and uncertainty
Our editorial standard is to trace important factual claims to original studies or official documents where available. Sources are listed on each article. A linked source does not by itself establish a claim; study design, population, outcomes, and limitations matter. Secondary reporting is identified as such.
AI assistance and editorial review
Articles are researched and written with AI assistance, then edited and checked against the primary sources listed on each page. They are not reviewed by a medical professional. No medical review is planned. AI can make mistakes; editorial source-checking is not clinical validation.
Dates and updates
Article dates indicate the stated publication or update date, not continuous monitoring. Regulatory information can change after publication. Substantive corrections should identify what changed and when; minor spelling and formatting fixes may be made without a correction note.
Reporting a correction
Use the Contact page to report an error. Include the article URL, the exact passage, why you believe it is incorrect, and a supporting primary source if available. Do not send private medical records. We assess reports against the evidence and correct material errors when confirmed; no response time is guaranteed.
Commercial relationships
Paid placements, commissions, gifts, or other relevant commercial relationships must be disclosed near the affected content. Compensation must not determine an article’s scientific conclusions. Our Affiliate Disclosure explains this policy.
Limits
We do not publish personal treatment plans or dosing protocols for unapproved peptides. Educational language and disclaimers do not replace accurate, supported claims.